X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

SAVA

Closed

Cassava Sciences Inc

1.85
+0.04 (+2.21%)
Last Update: 01 Jul 2025 23:20:00
Yesterday: 1.81
Day's Range: 1.76 - 1.9
Send
When Written:
 
24.12
Cassava Sciences Inc is a biopharmaceutical company that is focused on developing novel treatments for Alzheimer's disease. The company is based in Austin, Texas and was founded in 1998.

Cassava Sciences is currently developing a drug called PTI-125, which is a small molecule drug that targets the neuroinflammation associated with Alzheimer's disease. The drug has shown promising results in preclinical studies and is currently in phase 2 clinical trials.

In addition to PTI-125, Cassava Sciences is also developing a blood-based diagnostic test for Alzheimer's disease. The test is designed to detect a specific biomarker in the blood that is associated with the disease.

Cassava Sciences has a team of experienced scientists and drug developers who are dedicated to advancing the company's mission of developing effective treatments for Alzheimer's disease. The company is publicly traded on the NASDAQ under the ticker symbol SAVA.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X